2423 Administration of subcutaneous immunoglobulin (HIZENTRA<sup>®</sup>) in the home setting through the CSL Behring cares patient support program for patients with CIDP
Crossref DOI link: https://doi.org/10.1136/bmjno-2022-ANZAN.156
Published Online: 2024-02-01
Published Print: 2022-08
Update policy: https://doi.org/10.1136/crossmarkpolicy
Tognarini, David
Fenton, Kathryn
Youssef, Sherif
